Therapeutic Solutions International, Inc.
TSOI
$0.0001
$0.000.00%
OTC PK
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -67.36% | 30.65% | -1.25% | 60.26% | 36.40% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 0.00% | 62.00% | -12.21% |
| Total Amortization of Deferred Charges | 34.15% | -45.57% | -27.84% | -35.42% | -47.25% |
| Total Other Non-Cash Items | 592.75% | -2,086.21% | 838.05% | -121.70% | -80.19% |
| Change in Net Operating Assets | 507.43% | 369.70% | -996.18% | -76.84% | -46.70% |
| Cash from Operations | 122.76% | 57.46% | -2.19% | 46.45% | -54.09% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -3,448.15% | -- | -- | -102.15% | -- |
| Cash from Investing | -406.88% | -- | -- | -102.15% | -- |
| Total Debt Issued | -74.63% | -15.58% | 3.67% | -60.11% | 9.20% |
| Total Debt Repaid | -38.46% | 16.67% | -8.33% | -18.18% | -8.33% |
| Issuance of Common Stock | -100.00% | -90.29% | 14.60% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -91.28% | -77.32% | 15.83% | 66.14% | 200.61% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 102.74% | -148.34% | 5,040.00% | 34.55% | 68.06% |